VIR-7831 for the Early Treatment of COVID-19 in Outpatients
Volunteer for research and contribute to discoveries that may improve health care for you, your family, and your community!
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at Sacramento, California and other locations
- Dates
- study startedcompletion
Description
Summary
Official Title
Keywords
Eligibility
Locations
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- Sponsor
- Vir Biotechnology, Inc.
- Links
- Sign up for this study
- ID
- NCT04545060
- Phase
- Phase 2/3 COVID-19 Research Study
- Study Type
- Interventional
- Participants
- About 1057 people participating
- Last Updated